SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-07-053238
Filing Date
2007-03-13
Accepted
2007-03-13 13:25:03
Documents
5
Period of Report
2007-04-10
Effectiveness Date
2007-03-13

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT RE: SPECIAL MEETING ddef14a.htm DEF 14A 211324
3 GRAPHIC g93186g12c39.jpg GRAPHIC 9412
4 GRAPHIC g93186g88d11.jpg GRAPHIC 10359
5 GRAPHIC g93186g97z57.jpg GRAPHIC 7065
6 GRAPHIC g93186img001.jpg GRAPHIC 2116
  Complete submission text file 0001193125-07-053238.txt   253256
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12465 | Film No.: 07689965
SIC: 2834 Pharmaceutical Preparations